Global Drug Delivery Technology Market Size study, by Route of Administration and End User and Regional Forecasts 2022-2032

Description

The Global Drug Delivery Technology Market is valued approximately at USD 43.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.6% over the forecast period 2024-2032. Drug delivery systems represent a sophisticated method for administering therapeutic substances to achieve optimal therapeutic effects in humans and animals. These systems ensure the controlled release of active ingredients at the target site, enhancing efficacy and safety. The escalating demand for efficient delivery mechanisms for novel biopharmaceuticals is a significant driving force behind the market's expansion.

The surge in the incidence of chronic diseases, including cardiovascular diseases, diabetes, and cancer, coupled with rapid technological advancements and innovations, propels market growth. Additionally, the increasing focus on paediatric and geriatric patients, lifestyle changes due to urbanization, and the rising preference for minimally invasive surgeries further augment the demand for advanced drug delivery technologies. However, the market faces challenges such as side effects associated with drugs, patent expirations, and regulatory hurdles, which may impede growth. Despite these challenges, the market is poised for substantial growth, driven by rising investments in R&D and the growing biopharmaceutical market. The advantages of drug delivery technology, including enhanced efficacy, patient compliance, and targeted therapy, outweigh the disadvantages, positioning the market for continued expansion.

North America holds a prominent position in the global drug delivery technology market, accounting for a significant share due to heightened awareness of novel advancements and the presence of leading industry players. The United States and Canada dominate the regional market, contributing the majority of revenue. Meanwhile, the Asia Pacific region is expected to witness the fastest growth during the forecast period, driven by increasing healthcare investments and the adoption of advanced medical technologies.

Major market players included in this report are:

Johnson and Johnson Pvt. Ltd
3M
Novartis AG
Pfizer Inc.
GlaxoSmithKline PLC
Merck & Co. Inc.
Antares Pharma
Generex Biotechnology
Sivida Corporation
Alkermes

The detailed segments and sub-segment of the market are explained below:

By Route of Administration:

Oral Route
Parenteral Route
Subcutaneous Route
Transdermal Route
Inhalation Route
Nasal Drug Delivery

By End User:

Hospitals
Clinics
Diagnostic Centres
Home Care Settings
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Drug Delivery Technology Market Executive Summary

1.1. Global Drug Delivery Technology Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Route of Administration
- 1.3.2. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Drug Delivery Technology Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Drug Delivery Technology Market Dynamics

3.1. Market Drivers
- 3.1.1. Increasing Incidence of Chronic Diseases
- 3.1.2. Technological Advancements and Innovations
- 3.1.3. Growing Focus on Paediatric and Geriatric Patients
3.2. Market Challenges
- 3.2.1. Side Effects and Regulatory Hurdles
- 3.2.2. Inefficiency in Delivering Poorly Soluble Drugs
3.3. Market Opportunities
- 3.3.1. Rising Investments in R&D
- 3.3.2. Expanding Biopharmaceutical Market
- 3.3.3. Growing Demand for Minimally Invasive Surgeries

Chapter 4. Global Drug Delivery Technology Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Drug Delivery Technology Market Size & Forecasts by Route of Administration 2022-2032

5.1. Segment Dashboard
5.2. Global Drug Delivery Technology Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Oral Route
- 5.2.2. Parenteral Route
  - 5.2.2.4. Subcutaneous Route
- 5.2.3. Transdermal Route
- 5.2.4. Inhalation Route
- 5.2.5. Nasal Drug Delivery

Chapter 6. Global Drug Delivery Technology Market Size & Forecasts by End User 2022-2032

6.1. Segment Dashboard
6.2. Global Drug Delivery Technology Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Hospitals
- 6.2.2. Clinics
- 6.2.3. Diagnostic Centres
- 6.2.4. Home Care Settings
- 6.2.5. Others

Chapter 7. Global Drug Delivery Technology Market Size & Forecasts by Region 2022-2032

7.1. North America Drug Delivery Technology Market
- 7.1.1. U.S. Drug Delivery Technology Market
  - 7.1.1.1. Route of Administration breakdown size & forecasts, 2022-2032
  - 7.1.1.2. End User breakdown size & forecasts, 2022-2032
- 7.1.2. Canada Drug Delivery Technology Market
7.2. Europe Drug Delivery Technology Market
- 7.2.1. UK Drug Delivery Technology Market
- 7.2.2. Germany Drug Delivery Technology Market
- 7.2.3. France Drug Delivery Technology Market
- 7.2.4. Spain Drug Delivery Technology Market
- 7.2.5. Italy Drug Delivery Technology Market
- 7.2.6. Rest of Europe Drug Delivery Technology Market
7.3. Asia-Pacific Drug Delivery Technology Market
- 7.3.1. China Drug Delivery Technology Market
- 7.3.2. India Drug Delivery Technology Market
- 7.3.3. Japan Drug Delivery Technology Market
- 7.3.4. Australia Drug Delivery Technology Market
- 7.3.5. South Korea Drug Delivery Technology Market
- 7.3.6. Rest of Asia Pacific Drug Delivery Technology Market
7.4. Latin America Drug Delivery Technology Market
- 7.4.1. Brazil Drug Delivery Technology Market
- 7.4.2. Mexico Drug Delivery Technology Market
- 7.4.3. Rest of Latin America Drug Delivery Technology Market
7.5. Middle East & Africa Drug Delivery Technology Market
- 7.5.1. Saudi Arabia Drug Delivery Technology Market
- 7.5.2. South Africa Drug Delivery Technology Market
- 7.5.3. Rest of Middle East & Africa Drug Delivery Technology Market

Chapter 8. Competitive Intelligence

8.1. Key Company SWOT Analysis
- 8.1.1. Company
- 8.1.2. Company
- 8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
- 8.3.1. Johnson and Johnson Pvt. Ltd
  - 8.3.1.1. Key Information
  - 8.3.1.2. Overview
  - 8.3.1.3. Financial (Subject to Data Availability)
  - 8.3.1.4. Product Summary
  - 8.3.1.5. Market Strategies
- 8.3.2. 3M
- 8.3.3. Novartis AG
- 8.3.4. Pfizer Inc.
- 8.3.5. GlaxoSmithKline PLC
- 8.3.6. Merck & Co. Inc.
- 8.3.7. Antares Pharma
- 8.3.8. Generex Biotechnology
- 8.3.9. Sivida Corporation
- 8.3.10. Alkermes

Chapter 9. Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes